Ranbaxy Chairman To Sell Stake

10 June 1997

Ranbaxy of India's chairman, Parvinder Singh, has sought permission fromthe Indian government to privately place a maximum of 3.5 million shares with an overseas special purpose vehicle to raise around 2 billion rupees ($55.9 million) to retire some old and expensive debts, according to local drug industry sources.

These sources said Mr Singh and his investment companies, through which he holds the stake in Ranbaxy, had borrowed funds to convert warrants issued in June 1994. The warrants were converted in 1996 and Mr Singh is offering the stock to pay off debt. It has not been decided yet which kind of shares will be used.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight